Reference
Poonawalla IB, et al. Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review. PharmacoEconomics : 14 Jun 2015. Available from: URL: http://doi.org/10.1007/s40273-015-0304-9
Rights and permissions
About this article
Cite this article
First-line platinum-taxane combo cost effective in ovarian cancer. PharmacoEcon Outcomes News 731, 16 (2015). https://doi.org/10.1007/s40274-015-2245-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2245-0